Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.
about
Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patientsOcclusion of left atrial appendage affects metabolomic profile: focus on glycolysis, tricarboxylic acid and urea metabolism.Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.Frontiers of lipid research: cholesterol variability, HDL biogenesis, genetics of myalgia, and lipoprotein(a).Cholesterol efflux in the transplant patient.The year in cardiology 2017: prevention.High-Density Lipoprotein in Chronic Kidney Diseases-The Devil Is in the Detail.
P2860
Q42706652-F07E41B7-638E-4618-B3EB-83BB16382100Q47698279-CBFCF7F5-1468-4487-B26E-69852F3FDAD3Q47860627-A26DA9E7-1080-41AD-87BD-53501D2BC0A3Q49557626-02A247C8-5223-45DC-9CD0-A22EAF6D2F61Q50027499-0589A9A6-8965-4DBD-AC60-98B3323CE7C6Q50193445-C45726AD-2A6D-4E8B-82FB-E0323C7B6B24Q52374541-3BE9CAF5-B10A-4646-A27E-09B446A5F268
P2860
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.
@en
type
label
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.
@en
prefLabel
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.
@en
P2093
P2860
P50
P356
P1476
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.
@en
P2093
Alexander Dressel
Andreas Meinitzer
Andreas Ritsch
Christa Meisinger
Danilo Fliser
Edzard Schwedhelm
Ioannis Petrakis
Lucia Rohrer
Marcus E Kleber
Margit Heier
P2860
P304
P356
10.1093/EURHEARTJ/EHX118
P50
P577
2017-03-31T00:00:00Z